Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001640334-21-000985
Filing Date
2021-04-20
Accepted
2021-04-20 18:03:54
Documents
1
Period of Report
2021-03-25

Document Format Files

Seq Description Document Type Size
1 FORM 3 form3.html 3  
1 FORM 3 form3.xml 3 5315
  Complete submission text file 0001640334-21-000985.txt   6746
Mailing Address 57 WEST 57TH STREET SUITE 400 NEW YORK NY 10019
Business Address 57 WEST 57TH STREET SUITE 400 NEW YORK NY 10019 646-612-7554
Cell Source, Inc. (Issuer) CIK: 0001569340 (see all company filings)

EIN.: 320379665 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 341 LAKEWOOD DRIVE BLOOMFIELD HILLS MI 48304
Business Address
Soave Darlene (Reporting) CIK: 0001856892 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-55413 | Film No.: 21838973